ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.3106C>T (p.Arg1036Cys) (rs61729664)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000252526 SCV000320010 likely benign Cardiovascular phenotype 2017-07-31 criteria provided, single submitter clinical testing Lines of evidence used in support of classification: Other strong data supporting benign classification
Athena Diagnostics Inc RCV000586186 SCV000842846 benign not provided 2017-12-21 criteria provided, single submitter clinical testing
Biesecker Lab/Clinical Genomics Section,National Institutes of Health RCV000035561 SCV000054762 benign not specified 2013-06-24 criteria provided, single submitter research
Color RCV000771353 SCV000903642 likely benign Cardiomyopathy 2018-03-05 criteria provided, single submitter clinical testing
DNA and Cytogenetics Diagnostics Unit,Erasmus Medical Center RCV000625353 SCV000745033 likely benign Familial hypertrophic cardiomyopathy 4 2017-07-12 criteria provided, single submitter clinical testing
GeneDx RCV000035561 SCV000207993 likely benign not specified 2017-11-28 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Integrated Genetics/Laboratory Corporation of America RCV000586186 SCV000696327 likely benign not provided 2017-03-20 criteria provided, single submitter clinical testing Variant summary: The MYBPC3 c.3106C>T (p.Arg1036Cys) variant involves the alteration of a conserved nucleotide and 4/4 in silico tools (Polyphen not captured here due to not functioning at time of scoring) predict a damaging outcome, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 62/120392 (1/1941), predominantly in the African cohort, 58/9778 (1/168), which does exceed the estimated maximal expected allele frequency for a pathogenic MYBPC3 variant of 1/999. Therefore, suggesting this is likely a benign polymorphism found primarily in population(s) of African origin. Multiple publications have cited the variant in affected individuals, however, with limited information (ie, co-occurrence and cosegregation data) and predominantly classifying the variant as "likely benign." In addition, multiple clinical diagnostic laboratories have classified the variant as "likely benign/benign." Therefore, the variant of interest has been classified as "likely benign."
Invitae RCV000230224 SCV000284238 benign Hypertrophic cardiomyopathy 2017-08-15 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000035561 SCV000059211 likely benign not specified 2015-10-22 criteria provided, single submitter clinical testing p.Arg1036Cys in exon 29 of MYBPC3: This variant is not expected to have clinical significance because it is not located within the splice consensus sequence and has been identified in 0.6% (58/9778) of African chromosomes by the Exome Aggre gation Consortium (ExAC,; dbSNP rs61729664).
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease,Montreal Heart Institute RCV000035561 SCV000740364 likely benign not specified 2017-03-30 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.